Current Status of Gendicine in China: Recombinant Human Ad-p53 Agent for Treatment of Cancers
Top Cited Papers
- 1 September 2005
- journal article
- review article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 16 (9) , 1016-1027
- https://doi.org/10.1089/hum.2005.16.1016
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and ApoptosisScience, 2004
- NKG2D ligands: unconventional MHC class I‐like molecules exploited by viruses and cancerTissue Antigens, 2003
- Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cellsOncogene, 2002
- Multidrug resistance (MDR) in cancerEuropean Journal of Pharmaceutical Sciences, 2000
- Administration of wild-type p53 adenoviral vector synergistically enhances the cytotoxicity of anti-cancer drugs in human lung cancer cells irrespective of the status of p53 geneCancer Letters, 2000
- Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in miceOncogene, 2000
- Cell Surface Trafficking of Fas: A Rapid Mechanism of p53-Mediated ApoptosisScience, 1998
- Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma.Journal of Clinical Oncology, 1998
- The Nuclear ABC1 Gene is Essential for the Correct Conformation and Functioning of the Cytochrome bc1 Complex and the Neighbouring Complexes II and IV in the Mitochondrial Respiratory ChainEuropean Journal of Biochemistry, 1997
- Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1Science, 1994